Will Durham’s Emergo Therapeutics be fourth big startup hit for Moise Khayrallah?
Moise Khayrallah, Ph.D., is a serial entrepreneur with a Midas touch. Three biopharmaceutical start-ups he co-founded in recent years were quickly sold to larger companies for more than $400 million after he and his teams built their value from scratch. Will Emergo be number four?
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed